Implantable Exenatide (Byetta)

If you:

  • Have type 2 diabetes
  • Are treated with diet and exercise OR oral anti-diabetic agents
  • And have an A1C ≥ 7.5

You may be eligible to participate in a clinical study for a new investigation implantable version of the FDA approved medication Exenatide (Byetta).

For more information, please contact Marie-Laure Névoret, MD or 757-446-5106.



This study was approved by an EVMS IRB (Pro-00007502 and Pro-00008112)